EC Number |
Natural Substrates |
---|
1.1.1.B40 | 11-dehydrocorticosterone + NADPH |
isozyme 11beta-HSD1 |
1.1.1.B40 | 11beta,17,21-trihydroxy-pregn-4-ene-3,20-dione + NAD+ |
i.e. cortisol |
1.1.1.B40 | 11beta,21-dihydroxypregn-4-en-3,20-dione + NAD+ |
isoform 11beta-HSD2 |
1.1.1.B40 | 11beta,21-dihydroxypregn-4-en-3,20-dione + NAD+ |
i.e. corticosterone |
1.1.1.B40 | 11beta,21-dihydroxypregn-4-en-3,20-dione + NAD+ |
i.e. corticosterone, clear but not exclusive preference for NAD+, only oxidative activity |
1.1.1.B40 | 11beta,21-dihydroxypregn-4-en-3,20-dione + NAD+ |
i.e. corticosterone, no enzyme activity in reverse reaction direction |
1.1.1.B40 | 11beta,21-dihydroxypregn-4-en-3,20-dione + NAD+ |
i.e. corticosterone, significant higher rate of conversion for 11-beta-HSD2 than for 11-beta-HSD1 |
1.1.1.B40 | 11beta-hydroxytestosterone + NAD+ |
- |
1.1.1.B40 | 17,21-dihydroxy-pregn-4-ene-3,11,20-trione + NADH |
i.e. cortisone |
1.1.1.B40 | 17,21-dihydroxy-pregn-4-ene-3,11,20-trione + NADH |
important role in modulating mineralocorticoid and glucocorticoid receptor occupancy by glucocorticoids |